Proteomics analysis of methylglyoxal-induced neurotoxic effects in SH-SY5Y cells

Cell Biochemistry and Function

Volumn 29, Issue 1, 2011, Pages 30-35

  Li, Guoyi ^a,b   Chang, Ming ^a   Jiang, Huiyi ^a   Xie, Hongrong ^a   Dong, Zhong ^a   Hu, Linsen ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b Heilongjiang Province Hospital   (China)

Author keywords

Actin; Immunoglobulin lambda light chain; Methylglyoxal; Protein phosphatase 2; Proteomics; SH SY5Y cells

Indexed keywords

ACTIN; IMMUNOGLOBULIN LAMBDA CHAIN; METHYLGLYOXAL; PHOSPHOPROTEIN PHOSPHATASE 2;

ALZHEIMER DISEASE; ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NERVE CELL NECROSIS; NEUROTOXICITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS;

ACTINS; ALZHEIMER DISEASE; CELL DEATH; CELL LINE, TUMOR; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOGLOBULIN LAMBDA-CHAINS; NEUROTOXICITY SYNDROMES; PROTEIN PHOSPHATASE 2; PROTEINS; PROTEOMICS; PYRUVALDEHYDE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 78851471598     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1714     Document Type: Article

References (25)

1. de Arriba SG, Stuchbury G, Yarin J, et al. Methylglyoxal impairs glucose metabolism and leads to energy depletion in neuronal cells-protection by carbonyl scavengers. Neurobiol Aging 2007; 28: 1044-1050.
2. Lovell MA, Xie C, Markesbery WR. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging 2001; 22: 187-194.
3. Sheader EA, Benson RS, Best L. Cytotoxic action of methylglyoxal on insulin-secreting cells. Biochem Pharmacol 2001; 61: 1381-1386.
4. Webster J, Urban C, Berbaum K, et al. The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal. Neurotox Res 2005; 7: 95-101.
5. Du J, Suzuki H, Nagase F, et al. Methylglyoxal induces apoptosis in Jurkat leukemia T cells by activating c-Jun N-terminal kinase. J Cell Biochem 2000; 77: 333-344.
6. Akhand AA, Hossain K, Mitsui H, et al. Glyoxal and methylglyoxal trigger distinct signals for map family kinases and caspase activation in human endothelial cells. Free Radic Biol Med 2001; 31: 20-30.
7. Liu BF, Miyata S, Hirota Y, et al. Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cells. Kidney Int 2003; 63: 947-957.
8. Kuhla B, Luth HJ, Haferburg D, et al. Pathological effects of glyoxalase I inhibition in SH-SY5Y neuroblastoma cells. Neurosci Res 2006; 83: 1591-1600.
9. Amicarelli F, Colafarina S, Cattani F, et al. Scavenging system efficiency is crucial for cell resistance to ROS-mediated methylglyoxal injury. Free Radic Biol Med 2003; 35: 856-871.
10. Popovic S, Arsenijevic N, Baskic D. In vitro assay for the quantitative measurement of apoptotic lymphocytes phagocytosis by peripheral blood monocytes. Acta Physiol Hung 2006; 93: 325-333.
11. Zhang L, Chang M, Li H, et al. Proteomic changes of PC12 cells treated with proteasomal inhibitor PSI. Brain Res 2007; 1153: 196-203.
12. Aksenov MY, Aksenova MV, Butterfield DA, et al. Protein oxidation in the brain in Alzheimer's disease. Neuroscience 2001; 103: 373-383.
13. Powell SR, Gurzenda EM, Wahezi SE. Actin is oxidized during myocardial ischemia. Free Radic Biol Med 2001; 30: 1171-1176.
14. Banan A, Zhang Y, Losurdo J, et al. Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor alpha in a human colonic cell line. Gut 2000; 46: 830-837.
15. Dalle-Donne I, Rossi R, Giustarini D, et al. Actin carbonylation: from a simple marker of protein oxidation to relevant signs of severe functional impairment. Free Radic Biol Med 2001; 31: 1075-1083.
16. Poon HF, Vaishnav RA, Getchell TV, et al. Quantitative proteomics analysis of differential protein expression and oxidative modification of specific proteins in the brains of old mice. Neurobiol Aging 2006; 27: 1010-1019.
17. Korolainen MA, Nyman TA, Nyyssonen P, et al. Multiplexed proteomic analysis of oxidation and concentrations of cerebrospinal fluid proteins in Alzheimer disease. Clin Chem 2007; 53: 657-665.
18. Eikelenboom P, Stam FC. Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study. Acta Neuropathol 1982; 57: 239-242.
19. Kametani F, Tanaka K, Sato M, et al. A monoclonal antibody Hy20-54-16-3L to lambda (lambda) light chain of human immunoglobulin reacts with amyloid in Alzheimer's disease brain. Neurosci Lett 1990; 117: 62-67.
20. Liu R, McAllister C, Lyubchenko Y, et al. Proteolytic antibody light chains alter beta-amyloid aggregation and prevent cytotoxicity. Biochemistry 2004; 43: 9999-10007.
21. Hanger DP, Seereeram A, Noble W. Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease. Expert Rev Neurother 2009; 9: 1647-1666.
22. Gomez-Ramos A, Diaz-Nido J, Smith MA, et al. Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells. J Neurosci Res 2003; 71: 863-870.
23. Mattson MP, Fu W, Waeg G, et al. 4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau. Neuroreport 1997; 8: 2275-2281.
24. Liu F, Liang Z, Gong CX. Hyperphosphorylation of tau and protein phosphatases in Alzheimer disease. Panminerva Med 2006; 48: 97-108.
25. Su B, Wang X, Lee HG, et al. Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells. Neurosci Lett 2010; 468: 267-271.